| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/18/2004 | WO2004022576A2 Short peptides from the '2nd loop' of 7 transmembrane receptor which selectively modulate signal transduction |
| 03/18/2004 | WO2004022565A1 Multipurpose linker compounds and ligands and process for producing the same |
| 03/18/2004 | WO2004022133A2 Methods and apparatus for lancet actuation |
| 03/18/2004 | WO2004022091A1 Diacylglycerol production promoter |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022087A1 Use of disease-associated gene |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022082A1 Embryo implantation inhibitor |
| 03/18/2004 | WO2004022006A2 Methods of diagnosing cervical cancer |
| 03/18/2004 | WO2004022005A2 Regulation of the growth hormone/igf-1 axis |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021871A2 Hcv assay |
| 03/18/2004 | WO2004021857A2 Method for retrospective birth dating of biomolecules, cells, tissues, organs and organisms |
| 03/18/2004 | WO2004015422A3 Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) |
| 03/18/2004 | WO2004009845A3 Methods of screening for schizophrenia |
| 03/18/2004 | WO2004005930A3 Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases |
| 03/18/2004 | WO2004005925A3 Diagnostics method |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2004003505A3 Methods for detecting and inactivating a prion |
| 03/18/2004 | WO2004003168A3 Clustering biological data using mutual information |
| 03/18/2004 | WO2004001426A3 Method for identifying drugs for the treatment of alzheimer's disease |
| 03/18/2004 | WO2004001422A3 Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases |
| 03/18/2004 | WO2003104939A3 Health status data to optimize patient management |
| 03/18/2004 | WO2003102127A3 Human 5-ht7 receptor promoter sequence |
| 03/18/2004 | WO2003100557A3 Computer systems and methods for subdividing a complex disease into component diseases |
| 03/18/2004 | WO2003100434A3 Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2) |
| 03/18/2004 | WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 03/18/2004 | WO2003099289A3 Compositions and their uses for alleviating pain |
| 03/18/2004 | WO2003099210A3 Methods of modulating tubulin deacetylase activity |
| 03/18/2004 | WO2003096018A3 Kit for assay development and serial analysis |
| 03/18/2004 | WO2003093794A3 Methods for discovering tumor biomarkers and diagnosing tumors |
| 03/18/2004 | WO2003093307A3 Mycobacterial antigens and uses thereof |
| 03/18/2004 | WO2003092684A8 TIME-RESOLVED FLUORESCENCE ASSAY FOR THE DETECTION OF MULTIMERIC FORMS OF A-β[BETA] OR OTHER AGGREGATING POLYPEPTIDES |
| 03/18/2004 | WO2003089652A3 Comparative phenotype analysis of cells, including testing of biologically active compounds |
| 03/18/2004 | WO2003089594A3 A device and methods for concentrating prion protein isoforms |
| 03/18/2004 | WO2003087827A3 Multi-parameter assays including analysis discs and methods relating thereto |
| 03/18/2004 | WO2003081257A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
| 03/18/2004 | WO2003078660A3 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith |
| 03/18/2004 | WO2003078583A3 Optimization of crossover points for directed evolution |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003074997A3 Detection of carbon monoxide in hydrogen-based gas streams |
| 03/18/2004 | WO2003073233A3 Sequence detection system calculator |
| 03/18/2004 | WO2003073135A9 A method and apparatus for quantifying progress of sample clean up with curve fitting |
| 03/18/2004 | WO2003070979A3 Materials and methods relating to cancer diagnosis |
| 03/18/2004 | WO2003069310A3 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
| 03/18/2004 | WO2003068987A3 Discriminative analysis of clone signature |
| 03/18/2004 | WO2003068147A3 Treatments for neurotoxicity in alzheimer’s disease |
| 03/18/2004 | WO2003067210A9 Methods and compositions for detecting the activation state of the multiple proteins in single cells |
| 03/18/2004 | WO2003066904A3 Methods for determining the response of cells to vegf and uses thereof |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003054523A3 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array |
| 03/18/2004 | WO2003054509A3 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 03/18/2004 | WO2003050531A3 Method for displaying loops from immunoglobulin domains in different contexts |
| 03/18/2004 | WO2003046609A3 System and method for irradiating a sample |
| 03/18/2004 | WO2003046548B1 System and technique for detecting foreign material in meat |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003041481A3 Novel optical method for diagnosis and staging of premalignant and malignant human colonic tissues |
| 03/18/2004 | WO2003038039A3 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003036434A3 A system and method for consensus-calling with per-base quality values for sample assemblies |
| 03/18/2004 | WO2003035831A3 Lrrcaps as modifiers of the p53 pathway and methods of use |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003029814B1 Neuropilin/vegf c/vegfr 3 materials and methods |
| 03/18/2004 | WO2003029280A3 Grb7: novel regulator of lymphocyte signaling |
| 03/18/2004 | WO2003026670A3 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 03/18/2004 | WO2003017818A3 Management of gastro-intestinal disorders |
| 03/18/2004 | WO2003014308A3 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 03/18/2004 | WO2003008927A3 Methods and substrates for monitoring binding to a solid phase using proximity based signal generation assays |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002103340A3 Method and device for the detection of trace amounts of a substance,using a piezoelectric crystal element |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002096930A3 Iap binding peptides and assays for identifying compounds that bind iap |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002093166A8 Method for qualitative and/or quantitative determination of gender, species, race and/or geographical origin of biological materials |
| 03/18/2004 | WO2002092834A3 High capacity assay platforms |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090578A3 Methods and means of histone methylation |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002082048A3 Structure/properties correlation with membrane affinity profile |
| 03/18/2004 | WO2002078516A3 Compositions and methods for the therapy and diagnosis of cancer |
| 03/18/2004 | WO2002076280A3 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 03/18/2004 | WO2002072768A3 ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME |
| 03/18/2004 | WO2002064816A9 Multiple determinants for metabolic phenotypes |
| 03/18/2004 | US20040055032 Pyrophosphatase stress-related proteins and methods of use in plants |
| 03/18/2004 | US20040055022 Compositions and methods for screening therapeutic agents |
| 03/18/2004 | US20040054474 Acoustic method for estimating mechanical properties of a material and apparatus therefor |
| 03/18/2004 | US20040054267 Small volume in vitro analyte sensor |
| 03/18/2004 | US20040054265 Psychological stress in humans |
| 03/18/2004 | US20040054264 Information processing method and system using medical examination device as medium |
| 03/18/2004 | US20040054262 Allergy test chamber |
| 03/18/2004 | US20040054190 Imaging prostate cancer |
| 03/18/2004 | US20040054160 Nucleic-acid ink compositions for arraying onto a solid support |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054144 Predicting biological functions and/or diseases associated with preferential polypeptides; proteomics; rational drug design and/or screening |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |